Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Steroids vs Surgery for Idiopathic Granulomatous Mastitis
NCT02959580Phase 4Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jan 2017
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hydrocortisone butyrate in idiopathic granulomatous mastitis (IGM), sponsored by Peking Union Medical College Hospital. Primary endpoint: Clinical response rate at 6 months. Status: unknown.
02
Drugs
hydrocortisone butyrate
03
Conditions
idiopathic granulomatous mastitis (IGM)
Beyond the preview
Go deeper on NCT02959580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02959580.